An agreement has been reached with UniHA that allows 1,500+ French public hospitals to utilize Lunit's breast AI solutions. This collaboration, in partnership with Fujifilm, grants widespread access to advanced technology for cancer diagnostics. The agreement was announced on September 11, 2025, in Seoul, South Korea. Lunit, a prominent AI provider in the field of cancer diagnostics and therapeutics, is listed as KRX:328130.KQ.